Chaolin Huang

发表

3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.

Ye-ming Wang, Xiaoying Gu, Jiuyang Xu, 2023, The Lancet. Respiratory medicine.

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.

Ye-ming Wang, Xiaoying Gu, Jiuyang Xu, 2024, New England Journal of Medicine.

Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study.

Hainv Gao, Xiahong Dai, Xian-gao Jiang, 2023, The Lancet. Infectious diseases.